Showing results (171-180 of 181) with videos related to
Sort By:
Pageof 19
Cell Death & Disease|July 31, 2024
Neutrophil extracellular traps characterize caseating granulomasLeticija Zlatar, Jasmin Knopf, Jeeshan Singh, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2025
Effectiveness of the BPaL(M) Regimen for Drug-Resistant Tuberculosis in Ukraine under Programmatic ConditionsVictor Naestholt Dahl, Ole Skouvig Pedersen, Tetiana Butova, et al.Immunotherapy|November 22, 2016
Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosisUyanga Batbold, Dmytro O Butov, Galyna A Kutsyna, et al.Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|January 1, 2020
Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed <i>M. vaccae</i> administered daily for one monthAldar S Bourinbaiar, Uyanga Batbold, Yuri Efremenko, et al.Terapevticheskii Arkhiv|October 26, 2022
[Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia]D S Bordin, R А Abdulkhakov, M F Osipenko, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 8, 2023
Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in UkraineOle Skouvig Pedersen, Tetiana Butova, Valeriy Kapustnyk, et al.The Lancet Regional Health. Europe|September 15, 2025
Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort studyOle Skouvig Pedersen, Tetiana Butova, Valerii Miasoiedov, et al.Terapevticheskii Arkhiv|April 1, 2016
[European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers]D S Bordin, O B Yanova, R A Abdulkhakov, et al.Terapevticheskii Arkhiv|June 30, 2020
[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]D S Bordin, Y V Embutnieks, L G Vologzhanina, et al.Terapevticheskii Arkhiv|February 1, 2019
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in RussiaD S Bordin, Yu V Embutnieks, L G Vologzhanina, et al.Pageof 19